In April 2004, JHU reported that inhibition of FAS with C-75 altered food-intake, resulting in significant weight loss in animals, with no evidence of neurotoxicity
Across all semaglutide treatment arms, the most frequent AEs were gastrointestinal disorders (most commonly nausea, diarrhoea and vomiting), the majority of which were mild/moderate in severity
Statistical analyses were performed using GraphPad Prism (version 9.0, GraphPad Software, San Diego, CA, USA)
Impurities can compromise chain elongation and reduce overall yield, which is critical when generating therapeutic peptides like GLP-1 analogs
Physician-Assisted Weight Loss Clinic As we develop a weight loss goal together, we take into account your nutritional preferences and daily activity
Treatment Optimisation If weight loss progress has plateaued or side effects are limiting adherence to your current regimen, switching medicines may help reinvigorate your weight management journey